January 8, 2026
On September 18, 2025, the OSSTF ELHT Board approved a motion to implement the mandatory Preferred Generic Program for specified non-biologic specialty drugs effective November 1, 2025. As part of this program, coverage for newly approved claims for certain non-biologic specialty drugs will be limited to the preferred generic equivalent drug available through MemberRx. In these cases, no portion of an associated brand name drug will be covered. This program is designed to generate additional savings for the OSSTF ELHT which will be used to help ensure the sustainability of the OSSTF Benefit Plans.
In rare instances, an individual cannot tolerate the generic drug, or it is therapeutically ineffective. When this happens, medical evidence can be submitted to support why the brand-drug is being prescribed by applying for an exception to the FACET team. Requests can be faxed to1-844-446-1575 or emailed to OTIP@facetprogram.ca.
The information in this document is provided by OSSTF Benefits for general information only. OSSTF Benefits endeavours to have all information current and accurate. We make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, or suitability of the information included. All information is subject to change without notice.
The information contained in this website is for general information purposes only. The information is provided by OSSTF Benefits and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk. All information on this website is subject to change without notice.